ESC Professional Premium Access

Non-vitamin K antagonist oral anticoagulants (NOACs) attenuate valvular calcification in patients with severe aortic stenosis

Congress Session

About the speaker

Ms Magdalena Kopytek

John Paul II Hospital, Krakow (Poland)
0 follower

5 more presentations in this session

Loss of ceramide synthase 5 reduces the development of aortic valve stenosis in mice with high fat diet.

Speaker: Ms L. Reese (Bonn, DE)

Thumbnail

Unravelling the role of SOCS3 in aortic valve stenosis

Speaker: Doctor H. Billig (Bonn, DE)

Thumbnail

Specific gene domains most commonly affected by CHIP-driver mutations predicting mortality in severe aortic stenosis after transcatheter aortic valve implantation

Speaker: Associate Professor S. Mas-Peiro (Frankfurt, DE)

Thumbnail

Histology-verified myocardial fibrosis and quantification in severe AS patients: correlation with non-invasive LV myocardial tissue assessment

Speaker: Doctor S. Maltes (Lisbon, PT)

Thumbnail

Autologous or bovine pericardium for aortic cusp replacement? Histomorphological and biomechanical properties as decision making tools

Speaker: Doctor C. Dittfeld (Dresden, DE)

Thumbnail

Access the full session

Pathomechanisms and treatment of valve disease

Speakers: Ms M. Kopytek, Ms L. Reese, Doctor H. Billig, Associate Professor S. Mas-Peiro, Doctor S. Maltes...
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

This platform is supported by

logo Novo Nordisk